ORIC PHARMACEUTICALS, INC. (ORIC) Free cash flow 2018–2025
ORIC PHARMACEUTICALS, INC. (ORIC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$111.7MFY2025 · since FY2018: -$21.2M → -$111.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.7M | +1.9% |
| FY2024 | -$113.8M | -31.6% |
| FY2023 | -$86.5M | -12.1% |
| FY2022 | -$77.2M | -27.7% |
| FY2021 | -$60.5M | -31.7% |
| FY2020 | -$45.9M | -89.0% |
| FY2019 | -$24.3M | -14.6% |
| FY2018 | -$21.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORIC financial trends
ORIC RevenueORIC Net incomeORIC Net marginORIC Gross profitORIC Gross marginORIC Operating incomeORIC Operating marginORIC Operating cash flowORIC Capital expendituresORIC Return on equityORIC Stock buybacksORIC Dividends paidORIC Total assetsORIC Total liabilitiesORIC Shareholders’ equityORIC overview →